Inventor · disambiguated record
Ying Wang
Also filed as: WANG YING · WANG YING-JIIN
14 granted patents·16 pending applications·180 citations·filing 1995–2025
90Inventor score
Files withCHENGDU EASTON BIOPHARMACEUTICALS CO LTD8HITACHI CHEMICAL CO LTD3KEYMED BIOSCIENCES CO LTD2SHANGHAI MIRACOGEN INC2XINJIANG TECHNICAL INST OF PHYSICS & CHEMISTRY CHINESE ACADEMY OF SCIENCES2
Top patents by PatentIndex Score
30 records- 0194US6696045B2Dentifrice compositions comprising a stable low water, phase comprising polyphosphate and ionic active ingredientsPROCTER & GAMBLE·Filed 2002·Granted Feb 24, 2004·102 cites·11 claims
- 0291US10564514B1Nonlinear optical crystal of cesium fluorooxoborate, and method of preparation and use thereofXINJIANG TECHNICAL INST OF PHYSICS & CHEMISTRY CHINESE ACADEMY OF SCIENCES·Filed 2019·Granted Feb 18, 2020·6 cites·5 claims
- 0379US10987430B2Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereofMABWELL SHANGHAI BIOSCIENCE CO LTD·Filed 2017·Granted Apr 27, 2021·2 cites·28 claims
- 0479US5532374AMethod of preparation of bis-quinolinesHITACHI CHEMICAL CO LTD·Filed 1995·Granted Jul 2, 1996·34 cites·10 claims
- 0578US10537555B2Complex of angiotensin receptor antagonist and neutral endopeptidase inhibitorCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 21, 2020·2 cites·19 claims
- 0674US9431643B2Separator of lithium-ion-battery preparation and method thereofDONGGUAN AMPEREX TECH LTD·Filed 2014·Granted Aug 30, 2016·2 cites·16 claims
- 0772US5648448AMethod of preparation of polyquinolinesHITACHI CHEMICAL CO LTD·Filed 1995·Granted Jul 15, 1997·26 cites·20 claims
- 0871US2025032633A1Antibody-drug conjugate and application thereofSHANGHAI MIRACOGEN INC·Filed 2024·Application pending·0 cites
- 0960US5786071AMethod of preparation of polyquinolinesHITACHI CHEMICAL CO LTD·Filed 1997·Granted Jul 28, 1998·6 cites·9 claims
- 1060US2023381336A1Antibody-drug conjugate and application thereofSHANGHAI MIRACOGEN INC·Filed 2021·Application pending·0 cites
- 1160US2025114579A1Drug delivery system, and preparation method and use method thereofUNIV BEIHANG·Filed 2023·Application pending·0 cites
- 1257US2025346573A1Azaquinolinone derivative, preparation method therefor and use thereofCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1357US2023190700A1Theaflavin composition capable of promoting wound healing as well as preparation method and use thereofUNIV ANHUI AGRICULTURAL·Filed 2023·Application pending·0 cites
- 1456US2023330257A1Development of drug therapeutic agent containing adaptor and use thereofBEIJING TIANNUOJIANCHENG PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 1554US2025163016A1Pyridine derivative, preparation method therefor and use thereofCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1654US2025277045A1Development and application of t-cell engager therapeutic agentKEYMED BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1751US2024010646A1Urea Co-Crystal of Apixaban, and Preparation Method ThereforCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1851US2007078520A1Traceable nanocrystals and preparation thereofUNIV NAT YANG MING·Filed 2006·Application pending·0 cites
- 1950US2023111910A1Pd-1/pd-l1 inhibitor, preparation method therefor, and use thereofSHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 2049US2022372112A1Tumor therapeutic agent and use thereofKEYMED BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2148US9464128B2Site-specific pegylated linear salmon calcitonin analoguesLIU KELIANG·Filed 2008·Granted Oct 11, 2016·0 cites·8 claims
- 2248US2023357240A1Novel n-heterocyclic bet bromodomain inhibitor, and preparation method thereof and medical use thereofCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2347US2025388552A1Hydrate of vegfr inhibitor, crystal form thereof and preparation method thereforCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 2446US9815833B2Pyridine derivative and medical use thereofCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Nov 14, 2017·0 cites·9 claims
- 2543US11634388B2Crystal form of lenvatinib mesylate and preparation method thereforCHENGDU EASTON BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Apr 25, 2023·0 cites·6 claims
- 2642US2019137843A1Compound of cesium fluorooxoborate, nonlinear optical crystal of cesium fluorooxoborate, and method of preparation and use thereofXINJIANG TECHNICAL INST OF PHYSICS & CHEMISTRY CHINESE ACADEMY OF SCIENCES·Filed 2017·Application pending·0 cites
- 2739US9255098B2Xanthine derivativeCHENGDU EASTON PHARMACEUTICAL·Filed 2013·Granted Feb 9, 2016·0 cites·17 claims
- 2838US9493453B2Piperazinyl pyrimidine derivatives, preparation method and use thereofINST PHARMACOLOGY & TOXICOLOGY ACAD MILITARY MEDICAL SCIENCES PLA CHINA·Filed 2013·Granted Nov 15, 2016·0 cites·9 claims
- 2936US2013324542A1[1,2,4]triazolo[4,3-b][1,2,4]triazine compounds, preparation method and use thereofDUAN WENHU·Filed 2011·Application pending·0 cites
- 3035US8916567B2Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereofQUE FENG·Filed 2010·Granted Dec 23, 2014·0 cites·50 claims
Join the waitlist — get patent alerts
Get an alert when Ying Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →